SELLAS Life Sciences Group, Inc. (SLS) Total liabilities 2011–2023
SELLAS Life Sciences Group, Inc. (SLS) total liabilities at each fiscal year-end, per SEC filings.
$14.2MFY2023 · since FY2011: $20.9M → $14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $14.2M | -11.8% |
| FY2022 | $16.1M | +171.5% |
| FY2021 | $5.9M | -67.2% |
| FY2020 | $18.1M | +72.0% |
| FY2019 | $10.5M | — |
| FY2014 | $43.4M | -47.1% |
| FY2013 | $82.1M | +201.5% |
| FY2012 | $27.2M | +30.6% |
| FY2011 | $20.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice